Growth Metrics

Immuron (IMRN) Amortization (2016 - 2024)

Immuron's quarterly Amortization came in at $750920.1 in Q4 2024, up 56919.47% year-on-year from N/an in Q1 2024, and up 92.73% quarter-over-quarter from $389617.3 in Q2 2024.

Immuron has reported Amortization for 9 years, with the latest figure at $750920.1 in Q4 2024.

  • For the quarter ending Q4 2024, Amortization rose 56919.47% year-over-year to $750920.1; the trailing twelve-month figure through Dec 2024 stood at $750920.1 (up 118.84% YoY), and the FY2024 full-year result was $387739.2, up 122.35% from the prior year.
  • Amortization for Q4 2024 stood at $750920.1, up from $389617.3 in the prior quarter.
  • The five-year high for Amortization was $12.8 million in Q3 2023, with the low at -$3.1 million in Q2 2021.
  • Average Amortization over 5 years is $643740.4, with a median of $2021.0 recorded in 2021.
  • Year-over-year, Amortization tumbled 99.91% in 2021 and jumped 56919.47% in 2024.
  • Tracing IMRN's Amortization over 5 years: stood at $2.3 million in 2020, then plunged by 99.91% to $2021.0 in 2021, then climbed by 0.05% to $2022.0 in 2022, then tumbled by 34.87% to $1317.0 in 2023, then jumped by 56919.47% to $750920.1 in 2024.
  • The last three Amortization figures came in at $750920.1 (Q4 2024), $389617.3 (Q2 2024), and $1317.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortization (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -13.75 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Immuron 1.27 Bn 1.27 Bn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 750,920.05
Dec 31, 2024 750,920.05
Jun 30, 2024 389,617.25
Jun 30, 2024 389,617.25
Dec 31, 2023 1,316.95
Dec 31, 2023 1,316.95
Sep 28, 2023 12.82 Mn
Sep 28, 2023 12.82 Mn
Jun 30, 2023 -1.73 Mn
Jun 30, 2023 -1.73 Mn
Dec 31, 2022 2,022.00
Dec 31, 2022 2,022.00
Jun 30, 2022 -2.25 Mn
Jun 30, 2022 -2.25 Mn
Dec 31, 2021 2,021.00
Dec 31, 2021 2,021.00
Jun 30, 2021 -3.14 Mn
Jun 30, 2021 -3.14 Mn
Dec 31, 2020 2.31 Mn
Dec 31, 2020 2.31 Mn
Jun 30, 2020 -2.06 Mn
Jun 30, 2020 -2.06 Mn
Dec 31, 2019 80,148.00
Dec 31, 2019 80,148.00
Dec 31, 2018 414,443.00
Dec 31, 2018 414,443.00
Sep 28, 2017 4.52 Mn
Sep 28, 2017 4.52 Mn
Dec 31, 2016 2.77 Mn
Dec 31, 2016 2.77 Mn